Dag Hammarskjölds väg 52 A
Uppsala 752 37
Sweden
46 1 84 44 36 10
https://qlinea.com
Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 127
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Stuart Gander | Chief Executive Officer | N/A | N/A | 1978 |
Mr. Christer Samuelsson | CFO & IR | N/A | N/A | 1962 |
Mr. Henrik Jacobson | Chief Operating Officer | N/A | N/A | 1969 |
Ms. Ulrika Stolpe | HR Manager | N/A | N/A | 1967 |
Ms. Tiziana Di Martino | Chief Medical Officer | N/A | N/A | 1976 |
Mr. Thomas Fritz | Chief Commercial Officer | N/A | N/A | 1964 |
Mr. Anders Ljunggren | Managing Director | N/A | N/A | 1981 |
Ms. Victoria Lerneryd | Manager of QA/RA | N/A | N/A | 1984 |
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
Q-linea AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.